Medicare Enrolled

Dr. Paresh Patel, MD

Internal Medicine · Houston, TX
Practice pattern: Remote Monitoring — Significant remote device monitoring activity
Speaking/Promotional
13325 HARGRAVE RD STE 265, Houston, TX 77070
2818704567
In practice since 2008 (17 years)
NPI: 1508022484 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Paresh Patel is an internal medicine specialist in Houston, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 11,025 Medicare services across 3,281 unique beneficiaries.

Between the years covered by Open Payments, Dr. Patel received a total of $30,990 from 51 pharmaceutical and/or device companies across 471 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 3% volume in TX $30,990 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,025
Medicare services
Top 3% in TX for internal medicine
3,281
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~649 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Remote patient monitoring management, 20 min/month 2,622 $39 $70
Remote patient monitoring device, 30 days 1,731 $40 $80
Office visit, established patient (30-39 min) 980 $101 $200
Allergy skin test 880 $3 $18
Professional service for preparation and provision of single-dose vial of allergen 840 $13 $21
Allergy immunotherapy preparation 475 $12 $38
Hospital follow-up visit, moderate complexity 443 $64 $100
Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days 386 $43 $100
Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment 277 $15 $75
Evaluation of use of breathing device 257 $14 $50
Hospital follow-up visit, high complexity 223 $96 $150
Sleep study including heart rate, breathing, and sleep time 193 $120 $250
EEG, extended monitoring 193 $359 $650
Initial hospital admission, high complexity 175 $140 $300
Professional service for single injection of allergen 168 $8 $15
Test to examine how well the lungs exchange gases 164 $44 $100
Office visit, established patient (20-29 min) 139 $72 $150
Test to measure rate of airflow 130 $30 $75
New patient office visit (45-59 min) 130 $132 $250
Test to measure expiratory airflow and volume 107 $21 $50
Test to determine lung volumes using gas dilution or washout 90 $35 $75
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes 76 $31 $60
Test to determine lung volumes using sensors 73 $43 $100
Critical care, first 30-74 min 62 $173 $500
Test for exercise-induced lung stress 43 $27 $70
Test to measure expiratory airflow and volume changes before and after medication administration 32 $31 $75
Therapy procedure using a positive pressure ventilator 25 $51 $128
Flu vaccine administration 24 $30 $37
Flu vaccine, quadrivalent 23 $76 $100
Test to measure lung airway sensitivity 20 $49 $75
Transitional care management services for problem of at least moderate complexity 20 $165 $400
Inhalation treatment for airway obstruction or sputum production 12 $7 $30
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 12 $0 $30
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$30,990
Total received (2018-2024)
Avg $4,427/year across 7 years
Top 3% in TX for internal medicine
51
Companies
471
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16,310 (52.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,070 (26.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,610 (21.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,586
2023
$1,191
2022
$1,298
2021
$7,510
2020
$248
2019
$11,496
2018
$7,663

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$8,232
GlaxoSmithKline, LLC.
$7,428
AstraZeneca Pharmaceuticals LP
$6,990
Bayer HealthCare Pharmaceuticals Inc.
$2,080
Electromed, Inc.
$898
Actelion Pharmaceuticals US, Inc.
$836
Genentech USA, Inc.
$423
Pulmonx Corporation
$303
Janssen Pharmaceuticals, Inc
$278
JAZZ PHARMACEUTICALS INC.
$263
Mylan Specialty L.P.
$228
Shionogi Inc
$205
Regeneron Healthcare Solutions, Inc.
$176
CVRx, Inc.
$176
Jazz Pharmaceuticals Inc.
$169
Philips Electronics North America Corporation
$166
United Therapeutics Corporation
$157
Grifols USA, LLC
$152
GENZYME CORPORATION
$148
Respicardia, Inc.
$144
Axsome Therapeutics, Inc.
$142
Baxter Healthcare
$138
Sunovion Pharmaceuticals Inc.
$126
Mallinckrodt Hospital Products Inc.
$103
HARMONY BIOSCIENCES LLC
$102
Insmed, Inc.
$86
Astellas Pharma US Inc
$77
Pinnacle Biologics, Inc
$72
Harmony Biosciences LLC
$64
Olympus America Inc.
$55
Resmed Corp
$51
OptiNose US, Inc.
$48
Circassia Pharmaceuticals Inc
$44
Avadel CNS Pharmaceuticals, LLC
$43
Inspire Medical Systems, Inc.
$37
Esperion Therapeutics, Inc.
$34
Philips North America LLC
$34
Boston Scientific Corporation
$33
Allergan Inc.
$31
Amgen Inc.
$27
Advanced Respiratory, Inc
$25
Optinose US, Inc.
$23
kaleo, Inc.
$22
BOSTON SCIENTIFIC CORPORATION
$21
Chiesi USA, Inc.
$19
Medtronic Vascular, Inc.
$17
Veran Medical Technologies, Inc.
$14
EKOS Corporation
$14
Gilead Sciences, Inc.
$14
Merck Sharp & Dohme Corporation
$13
Novartis Pharmaceuticals Corporation
$11
Top 3 companies account for 73.1% of total payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AUVI-Q · AVYCAZ · Adempas · AirSense · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · Barostim Neo System · BodyGuardian · CHARTIS CATHETER · CRESEMBA · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · EKOSONIC · Esbriet · FASENRA · Fetroja · GENERAL BRONCHIAL THERMOPLASTY · HeartWare HVAD · INSPIRE · KENGREAL · LONHALA MAGNAIR · LUMRYZ · NEXLETOL · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Olympus Respiratory Accessories · PERCLOT · Photofrin · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · RESONATE · Respiratoriy Care Undiv · Respiratory Needles · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · Spiration Valve System · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Monarch Airway Clearance System · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · Utibron · WAKIX · Wakix · XARELTO · XOLAIR · XYREM · XYWAV · Xembify · Xhance · Xolair · Xyrem · YUPELRI · Yupelri · inCourage · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (53%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for internal medicine in TX.

Equivalent to $281 per 100 Medicare services performed
Looking for an internal medicine specialist in Houston?
Compare internal medicine physicians in the Houston area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
2,550
Per 100K population
53.6
County median income
$73,104
Nearest hospital
HOUSTON METHODIST WILLOWBROOK HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Patel is a remote monitoring specialist, with above-average Medicare volume (top 3% in TX), with speaking/promotional industry engagement in the top 3% of TX peers, with 17 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Patel experienced with remote patient monitoring management, 20 min/month?
Based on Medicare claims data, Dr. Patel performed 2,622 remote patient monitoring management, 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $30,990 from 51 companies across 471 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other internal medicine physicians in Houston?
Dr. Patel's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →